Literature DB >> 15104151

[Recent evolution of schistosomiasis in the water project of Sourou in Burkina Faso].

J N Poda1, S P Wango, H Sorgho, D Dianou.   

Abstract

In order to help the hydro-agricultural projects in the management of water resources together with a schistosomiasis control programme, it is important to evaluate the extent of the problem. This is the reason why parasitological and clinical surveys were conducted in schools associated with malacological surveys in transmission sites of several water projects including the one from Sourou. The data-collecting for the research on molluscs was carried out in surface water and as for parasitologic investigations on school-aged children, urine filtration and Kato-Katz were used to evaluate the parasitic load. The levels of prevalence were respectively in Guiédougou, Niassan, Di and Toma-île, in 2000, 60.5%, 40%, 48.8% and 51.9% for the urinary schistosomiasis, 5.3%, 0%, 6.9% and 50.6% for the intestinal schistosomiasis and in 2002, 56%, 51.9%, 51.6% and 43.4% for the urinary schistosomiasis, 10.1%, 8.2%, 22.7% and 90.8% for the intestinal schistosomiasis. The molluscs species collected and identified were: Biomphalaria pfeifferi for the intestinal schistosomiasis and Bulinus truncatus rohlfsi and B. senegalensis for the urinary schistosomiasis. B. senegalensis and B. truncatus were found naturally infested by S. haematobium. Water projects constitute amplifying factors of the proliferation of the species and parasitic exchange. All the actors (developers, populations, scientists) are questioning the means at their disposal to reduce the development of schistosomiasis which decrease the expected benefit of hydro-agricultural installations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15104151

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot        ISSN: 0037-9085


  6 in total

1.  Integrated monitoring and evaluation and environmental risk factors for urogenital schistosomiasis and active trachoma in Burkina Faso before preventative chemotherapy using sentinel sites.

Authors:  Artemis Koukounari; Seydou Touré; Christl A Donnelly; Amadou Ouedraogo; Bernadette Yoda; Cesaire Ky; Martin Kaboré; Elisa Bosqué-Oliva; María-Gloria Basáñez; Alan Fenwick; Joanne P Webster
Journal:  BMC Infect Dis       Date:  2011-07-12       Impact factor: 3.090

2.  Sustaining control of schistosomiasis mansoni in moderate endemicity areas in western Côte d'Ivoire: a SCORE study protocol.

Authors:  Rufin K Assaré; Stefanie Knopp; Nicaise A N'Guessan; Ahoua Yapi; Yves-Nathan T Tian-Bi; Patrick K Yao; Jean T Coulibaly; Mamadou Ouattara; Aboulaye Meïté; Alan Fenwick; Eliézer K N'Goran; Jürg Utzinger
Journal:  BMC Public Health       Date:  2014-12-17       Impact factor: 3.295

3.  Dynamics of freshwater snails and Schistosoma infection prevalence in schoolchildren during the construction and operation of a multipurpose dam in central Côte d'Ivoire.

Authors:  Nana R Diakité; Mirko S Winkler; Jean T Coulibaly; Négnorogo Guindo-Coulibaly; Jürg Utzinger; Eliézer K N'Goran
Journal:  Infect Dis Poverty       Date:  2017-05-04       Impact factor: 4.520

4.  High prevalence of helminths infection and associated risk factors among adults living in a rural setting, central Kenya: a cross-sectional study.

Authors:  Janet Masaku; Faith Mutungi; Paul M Gichuki; Collins Okoyo; Doris W Njomo; Sammy M Njenga
Journal:  Trop Med Health       Date:  2017-07-01

Review 5.  Invasion and Dispersal of Biomphalaria Species: Increased Vigilance Needed to Prevent the Introduction and Spread of Schistosomiasis.

Authors:  Mohamed R Habib; Shan Lv; David Rollinson; Xiao-Nong Zhou
Journal:  Front Med (Lausanne)       Date:  2021-02-10

6.  Current status of Schistosoma mansoni and the factors associated with infection two years following mass drug administration programme among primary school children in Mwea irrigation scheme: A cross-sectional study.

Authors:  Janet Masaku; Nancy Madigu; Collins Okoyo; Sammy M Njenga
Journal:  BMC Public Health       Date:  2015-08-01       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.